Search company, investor...

Predict your next investment

Asset/Investment Management
sparx.co.jp

Investments

6

About SPARX Asset Management

SPARX Asset Management, a subsidiary of SPARX Group, focuses on managing funds, which are investing in the listed and unlisted companies in Japan; providing consulting services and accounting to major corporations and high-net-worth clients in Japan; and promoting funds and providing client services in Japan.

Headquarters Location

Japan

Want to inform investors similar to SPARX Asset Management about your company?

Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.

Research containing SPARX Asset Management

Get data-driven expert analysis from the CB Insights Intelligence Unit.

CB Insights Intelligence Analysts have mentioned SPARX Asset Management in 1 CB Insights research brief, most recently on Jun 4, 2021.

Latest SPARX Asset Management News

SPARX : Mirai Creation Fund III Invests in Xcoo, a developer of Chrovis, a total solution software for genome and bioinformatics data analyses

Jul 11, 2022

07/11/2022 | 12:14am EDT Message : *Required fields The following is an English version of the official Japanese announcement, which has been given to the Tokyo Stock Exchange and the media in Tokyo, Japan. July 11, 2022 (Code: 8739, TSE Prime Market) Mirai Creation Fund III Invests in Xcoo, a developer of Chrovis, a total solution software for genome and bioinformatics data analyses -Promoting social implementation of cancer genome medicine by advanced computing technology- TOKYO-July 11, 2022-SPARX Group Co., Ltd. (SPARX; TSE Prime: 8739:) today announced that its Mirai Creation Fund III-established in October 2021-has executed an investment in Xcoo Inc., a startup firm which develops Chrovis, a total solution software for genome and bioinformatic data analysis, and provides services related to the software. Xcoo intends to utilize the raised capital to accelerate the expansion and development of Chrovis' functions and services to meet the growing needs on the clinical front lines, and the expansion of human resources to strengthen the team for this aim Portfolio Company Outline Xcoo, with the vison of "Technology bridge for communication", is a venture company originating from the University of Tokyo, specializing in genome medical analyses and bioinformatics. Xcoo has been developing and operating Chrovis, a total solution for genomic and bioinformatics analyses, employing its advanced technology and development capabilities. Chrovis also provides clinical-annotation,processes vast amounts of data across multiple databases and providing useful information to patients. Xcoo has received numerous startup-relatedawards, including the MEXT Minister's Award at Academic Startups 2019. ■ Mirai Creation Funds I, II, and III Summaries Mirai Creation Funds I, II, and III Summaries The Mirai Creation Fund I began operations in November 2015 with financing of JPY 13.5 billion from three companies: Toyota Motor Corporation, Sumitomo Mitsui Banking Corporation, and SPARX, the Fund's general partner. Ultimately, the Fund received contributions from 20 companies, including the above three. Casting intelligent technologies, robotics, and hydrogen- economy technologies as vital to the future, Fund I has invested in approximately 50 companies and projects-from the US, the UK, Israel, Singapore, and Japan-that possess innovations in these fields. In H2 2018, SPARX began managing the Mirai Creation Fund II, which targets the three existing Mirai Creation fields along with the two additional areas of electrification and new materials. In October 2021, SPARX launched the Mirai Creation Fund III with SPARX Asset Management Co., Ltd., a subsidiary of SPARX, acting as its fund manager, adding carbon neutrality to the five fields of the Mirai Creation Fund As of June 30, 2022, the combined AUM for Funds I, II, and III were JPY 151.1 billion. Mirai Creation Fund investment track record: https://mirai.sparx.co.jp/en/investment / For inquiries related to this release, contact: Public Relations, SPARX Group Co., Ltd. Tel: +81-3-6711-9100 / Fax: +81-3-6711-9101 pr_media@sparxgroup.com Attachments

SPARX Asset Management Investments

6 Investments

SPARX Asset Management has made 6 investments. Their latest investment was in OPTIMIND as part of their Series B on December 12, 2022.

CBI Logo

SPARX Asset Management Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

12/12/2022

Series B

OPTIMIND

$14.77M

Yes

5

4/26/2022

Series B

Subscribe to see more

$99M

Subscribe to see more

10

4/6/2022

Series A

Subscribe to see more

$99M

Subscribe to see more

10

3/28/2022

Series B

Subscribe to see more

$99M

Subscribe to see more

10

6/3/2021

Series A - II

Subscribe to see more

$99M

Subscribe to see more

10

Date

12/12/2022

4/26/2022

4/6/2022

3/28/2022

6/3/2021

Round

Series B

Series B

Series A

Series B

Series A - II

Company

OPTIMIND

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Amount

$14.77M

$99M

$99M

$99M

$99M

New?

Yes

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

5

10

10

10

10

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.